Cargando…

Characterization of the Pharmaceutical Risk-Sharing Arrangement Process in Catalonia

Pharmaceutical risk-sharing arrangements have emerged as a reasonable tool to promote sustainable access to innovative medicines with uncertain clinical evidence and/or economic impact from the payer perspective. These funding mechanisms pose an alternative option to the traditional fixed-price meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reyes-Travé, Anna, Guarga-Solé, Laura, Roig-Izquierdo, Marta, Alonso-Pérez, Enrique, Clopés-Estela, Ana, Delgadillo-Duarte, Joaquín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Practical Application
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352806/ https://www.ncbi.nlm.nih.gov/pubmed/34109568 http://dx.doi.org/10.1007/s40273-021-01046-1

Ejemplares similares

Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage
por: Maniadakis, Nikolaos, et al.
Publicado: (2018)

Management, Survival, and Costs of Pancreatic Cancer: Population-Based Observational Study in Catalonia
por: Guarga, Laura, et al.
Publicado: (2023)

Trends in lung cancer incidence by age, sex and histology from 2012 to 2025 in Catalonia (Spain)
por: Guarga, Laura, et al.
Publicado: (2021)

Shared Decision Making in a Youth Mental Health Service Design and Research Project: Insights From the Pan-Canadian ACCESS Open Minds Network
por: Guinaudie, Chloé, et al.
Publicado: (2020)

Changes in Treatment Patterns and Costs for Lung Cancer Have Not Resulted in Relevant Improvements in Survival: A Population-Based Observational Study in Catalonia
por: Guarga, Laura, et al.
Publicado: (2022)

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
por: Adamski, Jakub, et al.
Publicado: (2010)

Ventilator sharing moves forward
Publicado: (2020)

Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario
por: Duarte, Flavia A., et al.
Publicado: (2022)

Flagellar arrangements in elongated peritrichous bacteria: bundle formation and swimming properties
por: Clopés, Judit, et al.
Publicado: (2021)

Gastronomy Tourism and Well-Being: Evidence from Taiwan and Catalonia Michelin-Starred Restaurants
por: Lin, Min-Pei, et al.
Publicado: (2022)

MAP: Mutation Arranger for Defining Phenotype-Related Single-Nucleotide Variant
por: Baek, In-Pyo, et al.
Publicado: (2014)

Early Access to Medicines: Use of Multicriteria Decision Analysis (MCDA) as a Decision Tool in Catalonia (Spain)
por: Gasol, Montse, et al.
Publicado: (2022)

New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
por: Mapel, Douglas W., et al.
Publicado: (2012)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
por: O’Mahony, James F., et al.
Publicado: (2015)

Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
por: Angelis, Aris, et al.
Publicado: (2016)

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
por: Faria, Rita, et al.
Publicado: (2014)

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
por: Petrou, Stavros, et al.
Publicado: (2015)

Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
por: Oppe, Mark, et al.
Publicado: (2016)

A training paradigm to enhance performance and safe use of an innovative neuroendovascular device
por: Ricci, Donald R., et al.
Publicado: (2016)

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation
por: Dixon, Padraig, et al.
Publicado: (2016)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom
por: Whitehurst, David G. T., et al.
Publicado: (2018)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations
por: Shen, Jing, et al.
Publicado: (2018)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)
por: de Wit, Maarten, et al.
Publicado: (2016)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

Drug pricing and reimbursement information management: processes and decision making in the global economy
por: Tsourougiannis, Dimitrios
Publicado: (2017)

Balanced assessment systems revisited
por: Dankó, Dávid, et al.
Publicado: (2017)

Working with Patients and Members of the Public: Informing Health Economics in Child Health Research
por: Kandiyali, Rebecca, et al.
Publicado: (2018)

Measuring the Benefits of Decision Aids for Economic Evaluation
por: Butt, Thomas
Publicado: (2018)

Involving Patients in Health Economics Research: “The PACTS Principles”
por: Hawton, Annie, et al.
Publicado: (2020)

Telehealth and Nutrition Support During the COVID-19 Pandemic
por: Mehta, Pooja, et al.
Publicado: (2020)

Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic
por: Day, Alice S., et al.
Publicado: (2021)

Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19
por: Soofi, Moslem, et al.
Publicado: (2020)

Patient and Public Involvement (PPI) in Health Economics Methodology Research: Reflections and Recommendations
por: Al-Janabi, Hareth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3cplpe3gi7p4m0bpe2kcaemv5g